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ABSTRACT
CYTOTOXIC T CELL RESPONSE TO INFLUENZA
VACCINATION IN OLDER ADULTS
Caroline Reeve Letter
Old Dominion University, 2000
Director o f Advisory Committee: Dr. Janet McElhaney

Influenza infections result in activation o f cellular and humoral immune
responses, leading to stimulation o f cytotoxic T cells (CTL) and helper T cells with
subsequent viral clearance.

The increased morbidity and mortality from influenza

infections are associated with a decline in cellular mediated immunity.

Influenza

vaccination is recommended to prevent serious illness for all persons over the age o f 50
and is a cost-saving medical intervention.

Although animal models and cloned cell

lines have been used to study the cellular immune response to influenza, there are still
uncertainties about protective mechanisms against influenza in people due to the effect
o f aging on the CTL response.
While the duration o f the CTL response observed in older adults is sim ilar to
that o f young adults, the magnitude of the response is decreased.

This decrease in

magnitude o f the response is believed to occur due to a functional change in C D 8' T
cells, which may be associated with one o f the CTL mechanisms resulting in lysis o f
virus-infected cells - perforin-mediated killing and fas-mediated killing.

Perforin-

mediated killing has been shown to be particularly im portant for influenza virusspecific immunity and a very sensitive measure o f functional CTL.
In this research, the ex vivo T cell response was characterized using live
influenza A (H3N2) virus-stimulated ex vivo peripheral blood lymphocytes from
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healthy young and older adult populations. By using an assay o f granzym e B activity,
the in vivo ceilular-mediated immune response o f old adults was found to be
significantly decreased in comparison to young adults. The effect o f aging on the CTL
response was further investigated via enzyme-linked immunospot technique.

A

significant increase in number o f virus-specific T cells occurred in older adults after
vaccination, although the magnitude o f the CTL response decreased in comparison to
young adults. These data suggest that a mechanistic defect in the CTL response caused
the decreased response o f the CD8* T cells in older adults; and provides a basis for
further investigation o f age-related changes in the mechanism o f the CTL response to
influenza vaccination in older adults.
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CHAPTER I

INTRODUCTION

Influenza A and B viruses are negative-strand RNA viruses belonging to the
orthomyxovirus family. Both influenza viruses contain a segmented genom e consisting
o f eight single-stranded RNA molecules.

The segmented genome o f influenza virus

facilitates the development o f new strains o f influenza A and B viruses through the
reassortment o f genetic segments o f the influenza virus. This genetic instability leads to
the emergence o f new virus strains that evade the host immune system, and is
responsible for the annual epidemics o f influenza infection.
Influenza infections result in the activation o f the cellular and humoral immune
response, leading to antibody production and stimulation o f cytotoxic T cells (CTL) and
helper T cells with subsequent viral clearance.

Due to increased susceptibility to

influenza complications in the older adult population,

influenza vaccination

recommended to prevent illness and potential medical complications.

is

Both animal

models and cloned cell line systems have been used to study influenza, allowing the
cellular immune system response to influenza to be better understood.

There are still

uncertainties about the response to influenza in humans due to the differences in the
cytotoxic T lymphocyte memory and the effect of virus strain and aging on the CTL
response compared to similar experiments completed in animal models. CTL response

The model for this thesis is Journal o f Immunological Methods.
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is similar to the young adult population. The decline in cell mediated immunity in older
adults may be associated with a defect in one o f the CTL cytolytic mechanisms.

Epidemiology o f influenza
Acute respiratory illnesses, such as influenza, are believed to have afflicted
humans as early as the year 412 B. C. . Retrospective studies o f influenza epidemics in
humans in the 1890s (Webster et al., 1980; Cox et al., 1989) have shown that changes
within influenza viral proteins occurred, enabling the emergence o f new influenza virus
strains that evade the host immune system. The respiratory illness occurs mainly in the
winter months o f each year and disappears after several weeks o f circulation.
Influenza illness occurs m ore often in the elderly population than the young adult
population. Influenza and pneum onia represent the fourth leading cause o f death in the
elderly population (Couch et al., 1986; Kohn, 1986; Ferruci et al., 1997).

Influenza is

estimated to cause in excess o f 170,000 hospital admissions, resulting in excess o f
40,000 influenza-associated deaths at a cost o f $10 billion per year in the United States
(Read et al., 2000; Drinka et al., 1997; Brammer et al., 2000).
Influenza illness begins one to four days after virus infection o f the host.

An

initial headache can lead to the onset o f fever, nonproductive cough, and postnasal drip.
The influenza illness persists typically for approximately three days, while many have
symptoms for weeks. Although in the event o f complication(s) from influenza, recovery
is completed after seven to ten days (Douglas, 1975). Complications o f influenza illness
include pneumonia, which can lead to secondary bacterial pneumonia and bronchitis.
Influenza vaccination is recommended for all persons over 50 years o f age as it is
a cost saving medical intervention (Centers for Disease Control, 2000). The current
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vaccines are only 50-60% effective in preventing illness but at least 80-90% effective for
preventing serious illness in the healthy elderly population and may offer little protection
for the institutionalized older adult (Gross et al., 1995).

Antiviral drugs are able to

prevent or treat influenza infections, however the emergence o f drug-resistant strains o f
influenza virus, adverse drug reactions and cost o f antivirals limit the use o f these drugs
to individualized treatment (Hayden and Palese, 1997).

Viral replication of influenza
As with all viruses, influenza virus depends on the host cell enzymes to replicate.
The

influenza

viral

particle surface contains

glycoproteins,

hemagglutinin

and

neuraminidase. The binding o f hemagglutinin to the sialic acid residues located on the
host epithelial cell surface results in attachment o f the viral particle to the host cell
(Rogers et al.. 1985). Upon receptor-mediated endocytosis into the host cell (Marsh and
Helenius, 1989), the virion is internalized into endocytic vesicles (Figure 1).

The

influenza M2 protein within the virion cause the pH to decrease in secondary endosomes,
resulting in a conformational change in the hemagglutinin protein and uncoating o f the
virus, releasing the viral genome into the cytoplasm o f the host cell (W harton et al..
1990)

The eight RNA genomic segments o f influenza virus from the core o f the virus

travel to the nucleus o f the host cell.
Ribonucleoproteins, composed o f basic protein 1 (PB1), basic protein 2 (PB2),
acidic protein (PA), and nucleocapsid protein (NP), are encoded on one o f the eight
influenza virus RNA segments.

The nucleocapsid protein is believed to interact with

many regions o f the PB1. PB2 and PA RNA.

NP is known to contain antigenic

determinants o f the influenza virus. Thus, the conserved NP sequence is the major
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Fig. I: Viral replication.
The influenza vims attaches to the host cell and uses the host cell mRNA to produce new viral mRNA,
enabling the production of new vims.
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target o f cross-reactive cytotoxic T cell generated against all influenza virus subtypes.
Another type-specific antigen o f influenza virus is the matrix 1 protein (M l),
which is encoded on one o f the influenza virus RNA segments.

The amino acid

sequence o f M l is highly conserved among the influenza A virus subtypes. M l interacts
with the ribonucleoprotein structures. An interaction o f M l and NP has been proposed
to be required for the production o f the ribonucleoproteins (Yasuda et al., 1993).
Transcription into viral mRNA requires capped (m7GppNm -containing) RNA
fragments derived from host cell RNA polymerase II transcripts (Bouloy et al., 1978)
(Plotch et al., 1981), which are generated by a viral cap dependent endonuclease. Viral
mRNA chains are elongated by the addition o f a fifteen to twenty-two base stretch o f
uridine residues.

Transcription is then completed by the addition o f a polyadenylated

(poly A) tail (Hay et al., 1977; Robertson et al., 1981). The production o f full-length
viral mRNA transcripts is necessary for replication o f influenza virus. The viral template
RNAs or full-length copies o f cellular RNA are initiated without a primer and do not
terminate with a poly A tail. Template RNAs are copied into virus-specific m RNAs in
the nucleus o f the host cell and are translated into proteins in the cytoplasm.
Hemagglutinin and neuraminidase are synthesized on membrane bound ribosom es o f the
endoplasmic reticulum and translocated across the membrane o f the endoplasmic
reticulum into the smooth endoplasmic reticulum for maturation (Elder et al., 1979).
Once the glycoproteins have been correctly assembled within the endoplasmic reticulum,
the proteins are transported from the endoplasmic reticulum to the Golgi apparatus. The
viral RNAs and glycoproteins then form new influenza viral particles, which bud from
the surface o f the host cell. Completion of the influenza viral process occurs by pinching
o ff the budding particle at the host cell surface.
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Measurement o f immune responses to influenza
Humoral immune responses to influenza vaccines are measured via the
hemagglutination inhibition assay (Verbonitz et al., 1978).

Studies in the older adult

population have shown a decline in the cell-mediated immune response in comparison to
the young adult population, while there was little or no decline in the humoral immune
response (Ferry et al., 1979; Gross et al., 1989; Gross et al., 1997; Dorrell et al., 1997).
Although the efficacy o f influenza vaccination has been measured using antibody
responses to influenza, the antibody responses often do not predict protective immunity
in the older adults (Hobson et al., 1973). In young adults, the humoral immune response
to influenza vaccination has been found to fluctuate, and do not correspond with severity
o f influenza illness (Fries et al., 1993). These antibody assay studies suggest protection
from influenza infection may be more reliably measured using assays o f the cellmediated immune response in the older adult population.
The humoral and cell-mediated immune responses to infection with influenza
virus result in the production o f a variety o f cytokines by virus-activated T-cells. The
cytokines stimulate the

B-cells and T-cells.

The activated

B-cell

population

differentiates and produces antibodies specific for the strains o f influenza (A /H iN i,
A/H 3 N 2 , B) within the vaccine (Mitchell et al., 1985; Virelizier et al.. 1974).

The

antibodies bind to the glycoproteins, neuraminidase and hemagglutinin, on the surface o f
the viral particle resulting in the neutralization o f the viral particle. The virus is able to
evade the immune response induced from prior infection with related influenza viruses,
by naturally slightly altering the peptide sequences o f the viral glycoproteins (termed
antigenic drift) leading to outgrowth o f new influenza virus strains.

The changes o f

influenza virus resulting from antigenic drift necessitate annual modifications o f the

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

7
virus strains contained in the influenza vaccine if it is to remain antigenically sim ilar in
the subsequent season to the predicted circulating strains o f influenza.

Humoral and cellular immune responses to influenza
Influenza virus is initially taken up by antigen-presenting cells such as
macrophages and dendritic cells (Figure 2). Dendritic cells capture influenza virus or
influenza viral antigen and migrate into the draining lymph nodes where they stimulate
T-cell responses.

Dendritic cells are the most potent inducers o f T-cell responses

(Bender et al., 1996; Romani et al., 1996). The activated macrophages present influenza
viral proteins and produce proinflammatory cytokines to the T cells. The production o f
cytokines by the influenza virus-activated T cells results in stimulation of B cells to
differentiate and produce influenza strain-specific antibodies (Goidl et al., 1976).
Precursor cytotoxic T cell (CDS*) maturation towards lytic effector cells involves
a multi-step inductive process, composed of a variety o f regulatory events. Activation o f
precursor cytotoxic T cell requires co-stimulation through accessory and adhesion
molecules, as well as by receptors for lymphokines (Weiss and Littman, 1994). C D 4 ' T
cells and major histocompatability complex class II T cells regulate effector cytotoxic T
cell responses by providing stimulatory or inhibitory signals (Bretscher, 1992).

The

production of interleukin 2 by T helper type I cells and interleukin 4 by T helper type II
cells has been reported to be essential for the maturation o f precursor cytotoxic T cells
(W idmer et al.. 1987). A secondary stimulation o f the effector cytotoxic T cells with
influenza virus results in an immune response in the regional lymph nodes, resulting in a
significant increase in the number o f effector cytotoxic T cells (Flynn et al., 1988). The
effector cytotoxic T cells migrate to the spleen, where they become either terminally
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Fig 2: Immune Responses to Influenza Virus.
00

differentiated effector cytotoxic T cells or resting precursor memory cytotoxic T cells.
Upon presentation o f influenza virus antigen, precursor memory cytotoxic T cells
respond to internal influenza viral proteins (matrix protein, nucleocapsid proteins), which
are more conserved am oung influenza viral subtypes than highly variable surface
glycoproteins, and differentiate into effector memory cytotoxic T cells. Effector memory
cytotoxic T cells in mice respond to several influenza viral antigen peptides, thus
ensuring the ability to clear influenza virus infected cells despite the reassortment in
influenza glycoproteins (Van Bleek and Nathenson, 1990; Vitiello et al., 1996).
Influenza viral proteins are processed and presented as peptide antigens by the
major histocompatability complex to activate T cells. In contrast to cytotoxic T cells, T
helper cells recognize antigens presented by major histocompatability com plex class II,
which is expressed alm ost exclusively on cells o f the immune system (Hackett and
Eisenlohr, 1990; Dem otz et al., 1990).

Cytotoxic T cells recognize influenza viral

peptides on major histocompatability complex class I (Ennis et al., 1981).

While the

influenza viral peptides presented with major histocompatability com plex class I are
generally believed to be products o f viral replication within antigen presenting cells, the
presentation o f peptides on major histocompatability complex class I occur via nonclassical pathways. One o f these non-classical pathways o f activation occurs after the
presentation o f major histocompatability complex class I attached to antigen (Morrison et
al., 1986).

Thus, T helper cells and cytotoxic T cells have different requirements in

terms o f the form o f influenza virus required for stimulation.
Inactivated influenza virus vaccines stimulate cytotoxic T cells, as well as T
helper cells (Lamb et al., 1982; Askonas et al., 1982). Stimulation with live attenuated
influenza virus vaccines induce a better humoral immune response in serum or nasal
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mucosa than stimulation with inactivated influenza vaccines in children and young adults
while little or no response is observed in the older adult population (Clements et al.,
1984; Johnson et al., 1986).

Studies completed with live attenuated influenza virus

vaccines have resulted in a broader immune response to influenza, including the
production of secretory antibodies (Wright et al., 1982). The increased immune response
after stimulation with live attenuated influenza vaccines is believed to result from the
presence o f the influenza nucleoproteins (fragments of non-transmemebrane proteins
presented in their native confirmation rather than as a denatured protein fragment to the
cytotoxic T cell), which stimulate the cellular immune response (Townsend and
McMichael, 1985). The cellular immune response to live attenuated influenza vaccine
induce influenza virus specific cytotoxic T cells (Daisy et al., 1981; Ennis et al., 1981),
resulting from six influenza RNA genes (PB1, PB2, PA, NP, M, NS) and two genes
encoding influenza surface glycoproteins (hemagglutinin and neuraminidase) within the
live vaccine.
The cell types involved in the humoral and cellular mediated immune response
have been shown to vary in specificity to influenza.

However, the humoral immune

response changes in response to antigenic drift o f the various types o f influenza (Russell
and Liew, 1979; Butchko et al., 1978). The antigenic determinants o f the cell mediated
immune response (helper T cells and cytotoxic T cells) are more conserved within the
various types o f influenza (A/H3N2 vs. A/H1N1).

The peptides o f neuraminidase and

hemagglutinin serve as antigenic determinants o f the helper T cell response and are
cross-reactive within influenza subtypes H3N2 vs. H1N1 (Mitchell and Callard. 1983).
The nucleoproteins o f influenza virus are conserved within the types o f influenza
(A/H3N2 vs A/H1N1)

Cytotoxic T cell responses are stimulated by the internal viral
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proteins (nucleocapsid proteins, matrix proteins) and are cross-reactive for all strains
within influenza types A vs. B. While B cell memory for influenza is life-long, subtype
and strain-specific, T cell memory is more cross-reactive within various types o f
influenza due to the genetic similarities of the nucleoproteins o f the influenza subtype A
viruses (Fischer et al.. 1982). The duration o f T cell memory in response to influenza
vaccination has been shown to persist over periods from months to years in the healthy
young adult population (Ennis et al., 1981; McMichael et al., 1983). Understanding o f
the changes in magnitude o f T cell memory after influenza vaccination, especially in
older adults, should enable a better prediction o f the severity o f influenza illness.

Destruction o f influenza infected cells
Virus-specific cytotoxic T cells recognize and destroy virus-infected host cells.
Virus-infected cells expressing viral proteins on the major histocompatibilty com plex I
on the cell surface are recognized by and activate the cytotoxic T cells (Ennis et al.,
1981). Once the activation o f cytotoxic T cells has occurred, perforin-mediated killing
pathway (Podack et al., 1985; Masson and Tschopp. 1985; Pasternack and Eisen, 1985;
Bleackley et al., 1988; Jenne and Tschopp, 1988) and fas-mediated killing pathway (Itoh
et al., 1991; Rouvier et al., 1993) are activated, as well as an increase in the production o f
interferon-y (Ennis and Meager, 1981; Taylor et al., 1985; Yamada et al., 1986).

The

lytic properties o f perforin-mediated killing suggest this pathway play an important role
in the control o f viral influenza infection. Fas-mediated killing has been shown to be an
alternate pathway o f cell lysis (Doherty et al., 1997).
Cytotoxic T cells contain pore-forming proteins (perforins) and granzym es
(granzyme A through H) within the granules o f cytotoxic T cells.
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Activation o f

12
cytotoxic T cells, through contact with the viral infected target cell, results in the
mobilization o f granules to the surface o f the cytotoxic T cell (Shi et al., 1992; Shi et al.,
1997). The precursor form o f granzyme B is then processed by a dipeptidyl peptidase I,
enabling the removal o f an amino-terminal peptide, resulting in the activated form o f
granzyme B (Smyth et al.. 1995; Caputo et al., 1993; M cGuire et al., 1993). Granzyme
B can enter the cytoplasm o f the target cell, where it remains until perforin reaches the
target cell (Jans et al.. 1996; Pinokoski et al., 1996; Trapani et al., 1996). Through an
amphipathic pore complex created by 20-perforin monomers (Young et al., 1986), the
granzym es are also able to traffic across and enter the cytoplasm o f the target cell. The
presence o f perforin within the target cell enables granzyme B to enter the nucleus o f the
target cell (Trapani et al., 1996). The granzymes then initiate an enzym atic cascade,
which will lead to DNA fragmentation and cell death (apoptosis) (Helgason et al., 1993;
Darmon et al., 1995). One fundamental function o f granzyme B is to mimic the cleavage
specificity o f the caspase family o f pro-apoptotic cysteine proteases. Thus, granzyme B
is able to cleave the caspase precursors, resulting in the autocatalytic activation o f the
caspases which cause apoptosis (Femandes-Alnemri et al.. 1996; Darmon et al., 1996).
Fas-mediated killing results from the interaction o f fas ligand on the surface o f
activated cytotoxic T cell and fas receptor on the target cell. Fas ligand expression on the
cytotoxic T cell is up-regulated via signaling through the T-ceil receptor (TcR)-CD3
complex, resulting in the expression o f fas ligand on the surface o f the cytotoxic T cell
(Anel et al., 1994; Vignaux et al., 1995). Fas ligand expressed on the cytotoxic T cell
surface rapidly signals target cell apoptosis upon engagement o f the m em brane bound fas
receptor present on target cells (Hanabuchi et al., 1994; Suda et al., 1993; Ramsdell et al.,
1994) by activating a family o f caspases (“death domain”) in the intracellular terminus o f
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the fas receptor. The “death domain" contains many o f the caspases activated by
granzym e B, suggesting a convergence o f the two distinct pathways involved in
apoptosis (Depraetere and Goldstein, 1997; Atkinson et al., 1998).

The suggested

prim ary role o f fas-mediated killing is the downregulation o f the immune response by
eliminating autoreactive T cells in the periphery (Kagi et al., 1994; Mueller et al., 1998).
There is evidence that the dysregulation o f the fas/fas ligand regulatory mechanism and
perforin-mediated killing results in the acceleration o f lymphoproliferative disease and
mortality (Peng et al., 1998).

Thus, the expression o f fas ligand must be tightly

controlled because the presence o f fas on a number o f tissues within and outside the
im m une system could make uncontrolled expression deadly (Ogasawara et al., 1993).
A comparison o f perforin-mediated killing with fas-mediated killing (measured
by cytotoxic T cell cytotoxicity assays in the presence o f calcium) showed that perforindeficient cytotoxic T cells have significantly less cytolytic activity against influenza
infected cells (Lee et al., 1996). Once the lethal hit o f granzyme B is delivered to a target
cell via the perforin pore; the target cell will recognize the presence o f perforin and
granzym e B; although it has also been signaled to apoptose through the fas receptor.
Thus, perforin cytotoxicity in the presence o f calcium may mask fas-mediated killing.
The ability to clear influenza infected cells has been associated with an increase
in granzyme B production. The granzyme B gene is located at the 5’ flanking end on
chromosome 14; the genes for granzyme H, casthepsin G and mast cell chymase located
on chromosome 14 as well (Hanson and Ley, 1992). Granzyme B synthesis is believed
to be regulated by a locus-control-like element upstream o f the serine protease gene
cluster on chromosome 14. The locus-control-like element interacts with tissue-specific
elem ents near each gene to permit high-level, linear-specific expression o f the gene
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(Grosveld et al., 1987; Ley, 1991).

The expression o f granzyme B increases within

activated cytotoxic T cells, suggesting it plays a vital role in cytotoxic T cell-mediated
apoptosis (Mueller et al., 1998; Meier et al., 1990; Lobe et al., 1986).

The genetic

deletion o f perforin in mice resulted in the inability to clear influenza virus-infected
target cells, illustrating the necessity o f perforin for the mechanism o f cytotoxic T cellmediated killing (Kagi et al., 1994). A study in double knockout mice for granzyme A
and granzyme B showed granzyme B is required for the initial stages o f DNA
fragmentation in influenza virus infected cells, suggesting it plays a key role in viral
target cell lysis (Simon et al., 1997). These studies suggest that levels o f granzyme B
activity may be a critical component o f influenza specific viral immunity.

Effect o f aging on cytotoxic T cell response to influenza
The magnitude o f the cytotoxic T-cell response to influenza decreases in the
aging-mouse model (Bender et al., 1995). Both the mouse model and in vitro human
peripheral blood mononuclear cell cultures, provide evidence o f the decline in cytotoxic
T-cell activity with age (Effros and Walford. 1983; Powers, 1993; Thomas and Weigle,
1989). The effect o f aging on the cytotoxic T-cell response to influenza in human beings
has been shown to result in a decreased peak cytotoxic T-cell activity, while the duration
o f the cytotoxic T-cell response appears similar to the young adult population (Powers
and Belshe, 1993; M bawuike et al., 1993). While inactivated influenza vaccines are able
to stimulate the cytotoxic T cell in people (older and chronically ill adults), the use o f
live-attenuated vaccines increases the cross-reactivity o f the cytotoxic T-cell responses
for the subtypes o f influenza (Gorse and Belshe, 1990). The variations in the response to
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influenza in older adults may occur due to the type o f vaccine and ultimately, the way the
influenza antigens are presented to the immune cells.
The older adult population may have an increased susceptibility to complication
o f influenza infections due to a decreased T-cell response (Gottesman et al., 1985;
Powers and Belshe, 1993), rather than the primary B-cell failure (Goidl et al., 1976).
O lder healthy adults have decreased antibody responses to influenza due to the fact that
antibody responses are T-cell dependent (Levine et al.. 1987; Gross et al., 1988). The
variation in the immune response to influenza vaccination within the older adult
population may be due to chronic disease, prior exposure to influenza, and the aging
process (McElhaney et al., 1998). Studies regarding age-related changes o f the T cell
response to influenza vaccination have reported that the influenza virus-specific cellular
immune responses in older adults to be significantly reduced prior to vaccination in
comparison to the young adult population. The older adult population’s cytotoxic T-cell
response after influenza vaccination increased to the level observed in the young adult
population prior to vaccination, while the cytotoxic T cell response o f the young adult
population after vaccination remained similar to their response prior to vaccination
(Powers, 1993; McElhaney et al., 1994). Although studies by Ennis, G orse and Belshe,
and Plebanski have determined the cytotoxic T cell response to influenza vaccination,
none o f these studies have compared the responses between different age groups. The
regulation o f the cytotoxic T cell mechanisms which respond to influenza vaccination are
likely to be an important component of protection from influenza, especially for the older
adult.
Studies o f the cytotoxic T cell responses in people have been limited by the small
num ber o f participants and few have included older adults.

This has been due to the
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labor-intensive techniques required to complete chromium ( 5 lCr) release assays for
measuring cytolytic activity. The inter-assay variability o f the 5 ICr-release assay also has
prevented the direct comparison o f data from one study to the next.

5

ICr-release assays

require a six-day culture o f T-cells populations, such that proliferation and differentiation
under in vitro conditions may not reflect the in vivo in the response to vaccination. By
measuring granzyme B responses to influenza vaccination instead o f 5lCr release assays,
larger study groups can be used (McElhaney et al., 1996), and the inter-assay variability
o f the vaccine response measure reduced. Granzyme B is a m easure o f cytotoxic T cell
activity, which has substrate specificity due to an acetic acid side chain located at the
aspartyl residue (termed PI site) (Poe et al., 1991; Caputo et al., 1993; Odake et al.,
1991), allowing it to be measured via colorimetric detection o f the cleaved substrate.
The hydrolysis o f the preferred substrate o f granzyme B (N-t-butyloxycarbonyl-L-alanylL-alanyl-L-aspartyl-paranitroanilide) after the aspartic acid amino acid provides a
specific assay o f granzyme B (Odake et al.. 1991). A comparison study o f cytotoxic T
cel! response to influenza showed that measurement o f granzym e B activity is as
sensitive an indicator o f cytotoxic T cell activity as the

51

Cr-release assay (Butchko et al..

1978; McElhaney et al., 1996). Increased granzyme B activity have been found in virusstimulated peripheral blood mononuclear cells from institutionalized older adults after
influenza illness with lower respiratory tract symptoms (M cElhaney et al., 1994). The
granzyme B activity o f older adults appears to have decreased in response to the more
recently circulating compared to older strains o f influenza (M cElhaney et al., 1998). The
observed variations in magnitude o f the cytotoxic T cell response in older adults may
result from age-related changes in the cytotoxic T cell mechanisms.
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Research objectives
The cell-mediated immune response is affected by the aging process and results
in changes in the magnitude o f the cytotoxic T cell response. The decreased cytotoxic T
cell response in healthy older people may result from decreases in levels o f granzyme B
activity. The long-term objective o f this research is to identify components o f cytotoxic
T-cell killing (perforin-mediated killing and fas-mediated killing) which decline with
aging. This research will accomplish the following specific aims:
/.

To characterize the cytotoxic T cel! response to influenza vaccination in ex

vivo virus-activated peripheral blood mononuclear cells, as a measure o f the in vivo
response. Our hypothesis was that ex vivo virus-activated peripheral blood mononuclear
cells would respond similarly to the in vitro virus-activated

peripheral

blood

mononuclear cells in the young adult population. Using ex vivo and in vitro peripheral
mononuclear blood cells stimulated with three different live H 3 N 2 strains o f the influenza
subtype A virus, the ex vivo and in vitro levels o f granzyme B activity assay and virusspecific cytotoxic T cells were measured. The number o f influenza virus-specific CD 8 ‘
T cells were monitored using enzyme-linked immunospot (ELIspot) assay, quantitating
the number o f virus-specific memory cytotoxic T cells within the total cell population.
We expected the number o f influenza virus-specific T cells to correlate with the levels o f
granzyme B activity due to the fact granzyme B is produced within the cytotoxic T cells.
We compared the levels o f granzyme B activity in ex vivo and in vitro cultures for each
strain o f influenza virus to determine if there were independent effects from the in vitro
cell cultures, which may have affected the levels o f granzyme B activity. The number o f
virus-specific cytotoxic T cells and granzyme B levels were measured to distinguish
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between a qualitative and a quantitative difference in the response to influenza
vaccination.
2.

To determine the effect o f age on the T cell response in ex vivo virus-

stimulated peripheral blood mononuclear cells as a measure o f the in vivo response.
Our hypothesis was that the levels o f granzyme B activity are lower in vaccinated
healthy older adults in comparison to vaccinated healthy young adults. We determined
the effect o f age on the magnitude o f the cytotoxic T cell response to influenza in healthy
vaccinated older adults (<65 years). Using ex vivo and in vitro peripheral mononuclear
blood cells from healthy older people stimulated with three different live H3N2 strains o f
influenza subtype A virus, ex vivo and in vitro levels o f granzyme B activity and virusspecific cytotoxic T cells were measured. The ex vivo granzyme B levels were compared
to the in vitro granzyme B levels in each of the age groups. We expected the granzym e
B activity in the healthy older adults to be less than the young adults. We expected the
number of influenza virus-specific cytotoxic T cells to correlate with the ex vivo
granzyme B activity within the age groups. The determination o f the ex vivo cytotoxic T
cell response to various H3N2 strains o f influenza type A virus stimulation in older adult
people illustrated that the in vitro response to vaccination likely reflects the in vivo
influenza virus specific response.
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CHAPTER II

MATERIALS AND METHODS

Preparation of live influenza virus
Sixteen dozen fertilized chicken eggs were incubated for ten days in a high hatch
egg incubator (Catalog Number 2GHHI) (Murray M cMurray Hatchery, Inc., W ebster
City, IA) at 101°F. By holding the embryonated chicken eggs to a narrow light source,
the eggs were determined to be alive or dead in the presence or absence o f chicken
embryo movement. The eggs containing a live embryo were divided into three separate
groups and inoculated with influenza A/H 3 N 2 seed viruses (A/Sydney/05/97, or
A/Nanchang/933/95, or A/Johannesburg/33/94, which had been generously donated by
Dr. Nancy Cox at the Center o f Disease Control, Biological Products Division) and 2500
m g/1000 units o f penicillin/streptomycin. The inoculation site on the chicken eggs was
sealed with a drop o f Elm er’s glue. Several of the live chicken eggs were not inoculated
with influenza seed virus, enabling the production o f allantoic fluid, which was used as a
negative control in the following experiments.

The chicken eggs were incubated for

seventy-two hours in the egg incubator at I01°F and determined to be alive or dead in the
presence or absence o f chicken embryo movement.

Then, the live chicken eggs were

incubated overnight at 4°C (to kill the embryo).
The influenza virus was harvested as described by the viral harvesting protocol
from the University o f Wisconsin (a standard methodology). By opening o f the egg shell
housing the air sac around the chicken embryo, the shell membrane and chorio-allantoic
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membrane were able to be peeled away, enabling the removal o f allantoic fluid
containing live influenza virus.

The influenza virus was sterile filtered through 0.45

micron filtering units and stored at -80°C.

Titration o f influenza virus
The 50% tissue culture infective dose (TCID 5 0 ) o f live influenza virus was
determined as described by Cottey et al. (1997).

In a sterile round-bottom ed 96-well

plate, 90 pL o f D ulbecco’s minimum essential medium (DMEM) (Gibco BRL, Grand
Island, NY) supplemented with 5% fetal bovine serum, 50 pg/mL gentam icin, 100
units/mL penicillin, 100 pg/m L streptomycin and 2.5 pg/mL amphotericin B was added
into each well. A 200 pi aliquot of M adin-Darby canine kidney cells (concentration o f 2
x 105 cells/mL) was added to each well o f the plate. A 100 pL aliquot o f a 1:10 dilution
o f the stock influenza A/H 3 N 2 virus was pipetted into the first well.

The influenza

A/H 3 N 2 virus was serially diluted across the 96-well plate (wells numbered 2 to 11). 100
pL of DMEM supplemented with 5% fetal bovine serum, 50 pg/mL gentam icin, 100
units/mL penicillin, 100 pg/mL streptomycin and 2.5 pg/mL amphotericin B was added
to the well numbered 12 o f each row o f the plate, serving as the negative control. The
96-well plate was covered and incubated overnight at 37°C, 5% CO 2 . Following the
incubation, the supernatant (90 pL) contained in each well was aspirated and discarded.
A 200 pL aliquot o f DMEM supplemented with 0.0002% trypsin was added to each well
o f the plate. The plate was covered and incubated for 72 hours at 37°C, 5% C 0 2. The
plate was removed from the incubator and 50 pL of 0.5% chicken red blood cell
(Treslow Farms, Chester Town. MD)/phosphate buffered saline suspension was added to
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each well. After the 96-well plate had incubated for one hour at 4°C, the agglutination
patterns for the influenza A/H 3 N 2 virus was recorded. The 50% tissue culture infectious
dose (TCID 5 0 ) for the stock influenza A/H 3 N2 was calculated using the method o f Reed
and Muench (1938).

Isolation of peripheral blood mononuclear cells from venous blood
Peripheral blood mononuclear cells were isolated as described by McElhaney et
al. (1994) with minor modifications.

30 mL o f venous blood was collected in

heparinized tubes from the subject volunteers at several time points (prior to vaccination,
four weeks post vaccination, twelve weeks post vaccination, and thirty-six weeks post
vaccination). The venous blood sample was layered on a Ficoll-Paque (Sigma, St. Louis,
MO) and centifuged at 250 x g for 30 minutes. Peripheral blood m ononuclear cells were
collected from the interface and washed in phosphate buffered saline solution and
centrifuged at 250 x g for 12 minutes. The peripheral blood mononuclear cell pellet was
washed a second time in phosphate buffered saline solution and centrifuged for 250 x g
for 12 minutes. The cells were resuspended in 3 mL o f Aim V medium (Gibco BRL,
Grand Island, NY) and the cell number was calculated using a hem acytom eter The cells
were diluted to a final concentration o f 1.5 x 106 cells per mL in Aim V medium.

Production of Dynabeads coated with CDS6
Dynabeads were coated with purified anti-CD56 antibody (a surface marker for
natural killer cells) using the Dynal protocol from the package insert (Product Number
1 10.22, Dynal, Lake Success, NY), to remove natural killer cells from the peripheral
blood mononuclear cell cultures. 450 q.L o f Dynabeads Pan M ouse IgG was aliquotted
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into a 5 mL snapcap test-tube and placed in the Dynal MPC (magnetic device). The testtube containing the Dynabeads was attached to the magnetic device and the storage
solution was removed.

The Dynabeads were resuspended in 1 mL o f wash solution

(phosphate buffered saline/0.1% bovine serum albumin). The Dynabeads were washed
twice and resuspended in 450 pL o f wash solution.

Purified anti-CD56 antibody (1

pg/mL) (PharM ingen International. San Diego, CA) was added to 50 pL Dynabeads Pan
Mouse IgG (25 pL/1 pg o f antibody). Dynabead Pan Mouse IgG/antibody solution was
incubated for 30 minutes at 4°C with gentle tilting and rotation.

The Dynabeads Pan

Mouse IgG/antibody beads were separated from the supernatant using the magnetic
device for 2.5 minutes at 22°C. The anti-CD56 coated Dynabeads were washed three
times in I mL o f wash solution and resuspended in 450 pL wash solution.

The anti-

CD56 coated Dynabeads were used in the procedure for negative selection o f CD8 T
cells.

Negative selection for CD8+ T cells
Peripheral blood mononuclear cells were prepared at concentrations o f 1 x
I06cells/mL and were chilled to 4°C. Peripheral blood mononuclear cells were incubated
with 144 pL o f Dynabeads CD4" (which contain antibodies to CD4) (Dynal, Lake
Success. NY) and anti-CD56 coated Dynabeads (50 pL/mL o f cells) for 30 minutes at
4°C with gentle tilting and rotation. The peripheral blood mononuclear cells/Dynabeads
solution was placed into the magnetic device for 2.5 minutes at 22°C, to remove the
natural killer (NK) cells and CD4* T cells and ensure the only interferon-y producing
cells within the cultures would be CD8* T cells. The peripheral blood mononuclear cell
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supernatant was transferred into a fresh test-tube. The number o f CD 56' CD4' peripheral
blood mononuclear cells was determined for use in the ELIspot assay.

Depletion of CD8+ T cells
Peripheral blood mononuclear cells were prepared at concentrations of

1

x

106 cells/mL, chilled to 4°C, and incubated with 144 pL of Dynabeads CD 8 * (Dynal,
Lake Success. NY) for 30 minutes at 4°C with gentle tilting and rotation. The peripheral
blood mononuclear cells/Dynabeads solution was placed into the magnetic device for 2.5
minutes at 22°C, which allowed the collection o f the CD 8 * coated Dynabeads.

The

peripheral blood mononuclear cell supernatant was transferred into a fresh test-tube. The
num ber o f CD 8 ’ peripheral blood mononuclear cells obtained was determined for use in
the ELIspot assay.

E x vivo stimulation

Cell cultures were prepared at concentrations o f 2.25 x

106

cells/well in 24 well

plates (Costar. Corning International, Coming, NY). The cells w ere stimulated with live
influenza

A/H3N2

strains

(A/Sydney/05/97,

or

A/Nanchang/933/95,

or

A/Johannesburg/33/94) at a concentration of 105 TCIDso/mL and recombinant human
interleukin 7 at a concentration o f 25 ng/mL.

The cell cultures, which had been

stimulated were incubated for 17 hours (37°C, 5% CO 2 ). The cells were harvested via
scraping the well o f the plate with a pipette tip and collecting the cells and supernatant
into a 1 mL microfiige tube. The cell/supernatant mixture was centrifuged at 170 x g for
10

minutes. The supernatant was then aspirated and discarded.

The cell pellets were

lysed with 100 pL o f a lysis buffer (1% Triton X-100/150mM NaCl/15mM Tris-HCl, pH

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

24
8.0). Three freeze-thaw cycles (Incubation in ethanol/dry ice bath for 1 minute and 37°C
water bath for 1 minute, followed by through vortexing is the equivalent to one freezethaw cycle.) were completed on the cell lysates to ensure complete lysis had occurred.
The cell lysates were frozen at -80° C until time of assay for granzyme B activity. Cell
nuclei were pelleted from the lysate by centrifugation at 225 x g for 10 minutes at 4°C
prior to the assay for granzyme B activity.

In vitro stimulation
Cell cultures were prepared as described for the ex vivo stimulation procedure
with several modifications. The cell cultures were incubated for 6 days (37°C, 5% CO 2 )
in the absence o f recombinant human interleukin 7

Determination o f protein concentration
Total protein in the peripheral blood mononuclear cell lysates was measured
using the bicinchoninic acid (BCA) assay (Pierce Biotec Company, Rockford, 1L).
Bovine serum albumin (BSA) was used as the standard.

To determine the protein

concentration o f the cell lysates, the 2 mg/mL BSA stock solution was used to make the
solutions used in the standard curve.

The standard curve consisted o f the following

dilutions o f BSA in lysis buffer (1% Triton X-100/150mM NaCl/15mM Tris-HCl, pH
8.0) - 0 pg/mL BSA, 62.5 pg/mL BSA, 125 pg/mL BSA, 250 pg/mL BSA, 500 pg/mL
BSA, 750 pg/mL BSA, 1000 pg/mL BSA, 1500 pg/mL BSA, and 2000 pg/mL BSA. 10
pL of each standard or cell lysate sample was pipetted in triplicate into a 96 well flat
bottom plate. 200 pL o f BCA working reagent (50 parts BCA Solution A containing
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sodium carbonate, sodium bicarbonate, bicinchoninic acid, and sodium tartrate in 0.2 N
NaOH) and 1 part BCA Solution B (containing 4% CuSOj) was aliquotted into each
well. The plate was mixed on a plate shaker for 30 seconds. The plate was covered and
incubated at 37°C for 35 minutes. Following the incubation, the plate was allowed to
cool for 5 minutes at 22°C. The absorbance o f the samples was read at 562 nm using a
microtiter plate reader (PowerWave X, Bio-Tek Instruments, Inc.) using KC4 (Kinetcalc
for Windows).

The absorbance reading o f the blank sample was subtracted from the

standards and samples.

A standard curve was plotted to determine the protein

concentration o f the samples in mg of protein.

Preparation of YT lysates
YT (human natural killer leukemia cell line) cells were grown at a concentration
o f 1 x 10° cells/mL in RPMI 1640 medium supplemented with 10% fetal bovine serum,
0.1 mM 2-P-mercaptoethanol, 10 mM hepes (pH 7.2) (Gibco BRL, Grand Island, NY),
and 10 mM non-essential amino acids (Gibco BRL, Grand Island, NY). The YT cells
were stimulated with 90 units/mL o f interleukin 2 for 24 hours at 37°C, 5% C O 2 .
Following the incubation, the cells were centrifuged at 170 x g for 12 minutes.

The

supernatant was discarded and the cells were resuspended in 50 mL o f RPMI 1640
medium supplemented with 10% fetal bovine serum, 0.1 mM 2-P-mercaptoethanol, 10
mM hepes (pH 7.2), and 10 mM non-essential amino acids. The cells were incubated for
24 hours at 37°C, 5% CO 2 . Following the incubation, the cells were centrifuged at 170 x
g for 12 minutes. The supernatant was discarded and the cell density was determined.
The YT cells were centrifuged at 170 x g for 12 minutes. The supernatant was aspirated
and discarded.

Using the cell density, the volume o f lysis buffer (1% Triton X-100/
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150mM NaCl/15mM Tris-HCl, pH 8.0) which was added to the YT cell pellet was
determined by the following equation:

[Total live YT cells/2 x 106 cells] x 50 = pL of lysis buffer to be added

The YT cell pellet was lysed with the calculated volume o f lysis buffer.

Two freeze-

thaw cycles were completed on the YT cell lysate to ensure com plete lysis had occurred.
The initial concentration o f YT lysate was arbitrarily determined to be 100 units/mL. The
cell lysates were aliquotted into microfiige tubes, containing 30 pL volumes.
The YT lysates were calibrated by the completion o f a seven point standard
curve.

The YT lysates were diluted in lysis buffer using tw o fold dilutions from 50

units/mL to 0 units/mL.

10 pL o f the various dilutions o f the YT lysate was aliquotted

into a 96 well flat-bottom plate.

40 pL o f 2.5 mM Boc-Ala-Ala-Asp-paranitroanilide

(BACHEM, Torrance, CA) and 150 pL o f sterile distilled w ater were added to each well
in the plate. After a 18-hour incubation, absorbance o f the sam ples was read at 405 nm
using a m icrotiter plate reader (PowerWave X, Bio Tek Instruments, Inc.) using KC4
(Kinetcalc for Windows) and a standard curve was plotted. The initial YT preparation
standard curve was compared to further YT lysate preparations. Upon completion o f the
calibration o f the YT lysates, the lysates were frozen at -80° C until tim e of assay for
granzyme B activity.

Assay for granzym e B activity
Triplicate samples containing 10 pL o f peripheral blood mononuclear cell lysate
and 40 pL o f 2.5 mM Boc-Ala-Ala-Asp-paranitroanilide w as assayed for each sample in
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200 (iL reaction volumes.

Cell-lysates o f influenza-stimulated peripheral blood

mononuclear cell were prepared as described above. YT lysates as described above were
used as the standards for this assay.

Unstimulated peripheral blood mononuclear cell

(cultured on days 0 and 6) were included as negative controls. After a 12-hour
incubation, absorbance o f the samples was read at 405 nm using a microtiter plate reader
(PowerWave X, Bio-Tek Instruments, Inc.) using KC4 (Kinetcalc for W indows).

The

absorbance reading o f the blank sample was subtracted from the standards and samples.
A standard curve was plotted, enabling the granzyme B activity o f the samples to be
determined as units o f absorbance at 405 nm.
The granzyme B activity was reported as the units/mg protein in the lysate. The
granzyme B activity was determined in all cellular lysates using the following formulas:
lysate (units o f absorbance at 405 nm) -blank (units o f absorbance at 405 nm) = z

z/absorption at 405 nm o f YT lysate standard = y

y x concentration o f YT lysate standard(units) = granzyme B activity o f lysate

granzyme B activity o f lysate (units o f absorbance at 405 nm)
protein concentration o f the lysate (mg protein)

ELIspot assay o f interferon y
The number o f interferon gamma producing cells in the peripheral blood
mononuclear cell cultures was determined as described by Czerkinsky et al. (1983) with
minor modifications.

Ninety-six well nitrocellulose plates (Millititer, Millipore,

Bedford, MA) were coated with 50 pL mouse anti-human interferon y monoclonal
antibody (Mabtech, Stockholm, Sweden) in coating buffer pH 9.5 (15 mM Na2Coj/35
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mM N aH C O j/3.1 mM NaN3) overnight at 4°C. The wells were washed with phosphate
buffered saline (pH 7.3) (1.9 mM NaH 2 PC>4 / 8 I mM Na2HPCV154 mM NaCl)
supplemented with 0.25% Tween 20 (Sigma, St. Louis, MO) and blocked with phosphate
buffered saline supplemented with 5% fetal bovine serum for thirty minutes at 37°C. A
100

with

pL aliquot o f RPMI 1640 medium (Gibco BRT, Grand Island, NY) supplemented
10

% human anti-AB serum, 2 mM L-glutamine, 50 pM 2-P-mercaptoethanol, 100

units/mL penicillin and 100 pg/mL streptomycin was incubated on the plates for ten
minutes, diluting any remaining Tween 20.

Two fold dilutions o f an aliquot o f 100

pL/well o f peripheral blood mononuclear cells (concentration/well: 5 x 106/mL to 5 x
10

'VmL), from which CD56* (natural killer cells) and CD4* (T helper cells) had been

removed, were stimulated with three different H 3 N 2 strains o f live influenza A virus
(A/Sydney/05/97, or A/Nanchang/933/95, or A/Johannesburg/33/94) (concentration o f
105 TClDjo/mL) and 25 ng/mL interleukin-7 in the antibody-coated plates and incubated
for 17 hours (37°C, 5% C 0 2).

Serial dilutions o f unstimulated peripheral blood

mononuclear cells were added to the antibody-coated plates and incubated for 17 hours
(37°C, 5% C 0 2), serving as the negative control.

Serial dilutions o f peripheral blood

mononuclear cells stimulated with concanavalin A (10 pg/mL) were added to the
antibody-coated plates and incubated for 17 hours (37°C, 5% C 0 2), serving as the
positive control. The plates were washed thirteen times with phosphate buffered saline
supplemented with 0.25% Tween 20.

The wells were incubated with 50 pL o f

biotinylated polyclonal mouse anti-human interferon y antibody (Mabtech. Stockholm,
Sweden) in PBS supplemented with

1

% bovine serum albumin for two hours at 22°C.

After washing the wells six times with phosphate buffered saline/0.25% Tween 20, 100
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pL avidin-horseradish peroxidase (Sigma, St. Louis, MO) (1 pg/mL) was added for tw o
hours at 22°C. The wells were washed six times with phosphate buffered saline/0.25%
Tween 20 and then, 50 pL/well o f aminoethyl carbazole solution (Sigma, St. Louis, M O)
(70.3 pg/m L) was added and incubated for 30 minutes at 22°C. Washing the plates three
times with distilled water stopped the color development.

After allowing the plates to

air-dry, the colored spots were counted using a stereomicroscope.

Handling o f biohazardous materials
All tissue culture was completed in Forma Scientific Class IIA/B3 Safety
Cabinet.

All personnel involved in this project had been approved to handle

biohazardous materials by the Biosafety Committee at Eastern Virginia Medical School,
Norfolk, Virginia.

The protocols involving use of live influenza viruses had been

reviewed and approved by the Biosafety Committee at Eastern Virginia Medical School,
Norfolk, Virginia.

All procedures were in accordance with Eastern Virginia M edical

School Bloodborne Pathogens Plan and personnel were appropriately trained by the
Biosafety Committee at Eastern Virginia Medical School, Norfolk, Virginia.

Use of human subjects

This study was performed at the Glennan C enter for Geriatrics and Gerontology, Eastern
Virginia Medical School and was reviewed and approved by the Eastern Virginia
Medical School Institutional Review Board.
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Recruiting: Subjects eligible for each o f the studies (see criteria selection below) were
competent to sign an IRB approved consent.

Human participation required the

individual volunteers to be competent to give their own consent.

They were initially

asked by a health professional designated by the investigators if they were interested in
participating. If so, they were interviewed and those who offered, were enrolled with a
written, informed consent. For the studies, subjects were enrolled as follows:

Site: the Hampton Roads residential community and long-term care facilities around the
Glennan Center. Norfolk ranks second in population in Hampton Roads, with African
Americans comprising 39%. A recent recruitment effort targeted older adults belonging
to an ethnic minority group yielded 7% participation.

Criteria Selection: These young (ages 18 to 50, 12 females and 4 males) and older adults
(ages 63 to 85, 6 females and 4 males) were screened. Inclusion criteria w as based upon
the following for "healthy" subjects.

The inclusion criterions for subjects in the young and older adult populations
were based upon all o f the following points.
1

Ambulatory.

2

In reasonably good health.

3. Must not require legal or medical guardian.
4. Available for duration o f the study.
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The exclusion criterions for the subjects in the young and older adult populations
were based upon any o f the following points.
1. An acute febrile illness (temperature >100.4°F) within 72 hours prior to
enrollment in the study
2. Elevated vital signs during initial physical exam.
3.

Known or suspected allergy to any components o f the vaccine (i.e. eggs, or
egg products, thimerosal or contact lens solution, or fomaldehyde).

4.

Self-reported history o f severe adverse reaction to any vaccination.

5. Known or suspected disease o f the immune system.
6. Currently o r within 3 months o f enrollment taking immunosuppressive or
immunomodifying medication (i.e. cancer chemotherapeutic agents, steroids).
7. Diabetes being treated with insulin or oral hypoglycemic agents.
8.

Receipt o f blood or blood products within 3 months prior to enrollment.

9.

If female and o f child bearing potential, pregnant as confirmed by urine
pregnancy test.

Women > 60 years o f age were considered not o f

childbearing potential.
10. Receipt o f any vaccine in the previous 4 weeks or plans to receive another
vaccine during the 5 week study period.
11. Current participation in another clinical trial.
12. Participation in any other experimental drug or vaccine trial within the 30
days prior to enrollment.
13. Self-reported receipt o f any influenza vaccine since January 1 o f the study
year.
14. Previous therapy with cadaveric pituitary derived human growth hormone.
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15. Any condition, which, in the opinion o f the investigator, would pose a health
risk to the subject or interfere with the evaluation o f the vaccine (e.g.
pulmonary disease, cardiovascular disease, etc).

Influenza vaccine. Vaccination with the current influenza vaccine (0.5 mL dose) was a
requirement for participation in each year o f the study.
1999 contained

Influenza virus vaccine 1998-

15 pg o f hemagglutinin o f A/Sydney/05/97 (H 3 N 2 )-like strain.

A/Beijing/262/95 (HiN i)-like strain, and B/Beijing/184/93-like strain.

Influenza virus

vaccine 1999-2000 contained 15 pg o f hemagglutinin o f A/Sydney/05/97 (H 3 N 2 )-like
strain, A/Beijing/262/95 (HjNi)-like strain, and B/Beijing/ 184/93-like strain. The split
virus representing three difference strains o f influenza vaccine may change from year to
year as influenza viruses antigenically drift.

Risks: The risks o f this study involved those associated with the administration o f the
influenza vaccine, and phlebotomy and were determined to fall within the “minimal risk”
levels as defined by the FDA.

The United States Public Heath Service currently

recommends people over 65 years to be vaccinated as part o f their general health
maintenance.

From 10 to 30% o f such vaccine recipients may have experienced mild

myalgias lasting one to two days and up to 5% may have experienced a low-grade fever

Benefits:

Protection from influenza and its complications far outweighed the risks

associated with vaccination.
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Subjects had venipunctures performed on two to three occasions annually.

The risks

associated with venipuncture included acute mild pain and a remote chance o f bruising or
infection at the venipuncture site. There was no foreseeable risk associated with the
amount o f blood taken and the amount o f blood taken fell under the ‘‘minim al risk” level
as defined by the FDA.

Confidentiality: Every effort was made to maintain subject confidentiality. All subjects’
data was coded to protect the anonymity o f subjects enrolled in the study.
individually identifiable data will be published.

No

A complete record o f the subject’s

pertinent history, clinical progress, and results o f laboratory and diagnostic examination
was kept on case report forms (which were coded).

Statistical analysis
All data were processed using a computer program, SPSS 9.0.

Granzyme B

activity levels within the subject populations were initially analyzed by averaging the
granzyme B activity levels and calculating the 95% confidence intervals. The frequency
o f cytotoxic T cells within the subject populations was initially analyzed by averaging
the number o f interferon y producing cells and calculating the 95% confidence intervals.
The t distribution for the granzyme B activity levels (difference between 4 week post
vaccination value and prior to vaccination value) and probability (p) (significance level
set at a = 0.05) corresponding to the t distribution was calculated for the three different
influenza A/H 3 N2 strains.

Although the sample sizes o f the subject populations were

relatively small, the data was assumed to be normally distributed. M ann-W hitney U test
was used to determine the differences between the two age groups with respect to the
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different influenza A/H 3 N 2 strains on the granzyme B activity levels (difference between
4 week post vaccination value and prior to vaccination value), the frequency o f cytotoxic
T cells (difference between 4 week post vaccination value and prior to vaccination
value), and the ratio o f granzyme B activity per influenza virus-specific CD8

T cell.

Probability (p) (significance level set at a = 0.05) corresponding to the M ann-Whitney U
distribution was determined. Although the sample sizes of the subject populations were
relatively small, the data was assumed to be similarly distributed.
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CHAPTER III

RESULTS: INVESTIGATION OF GRANZYME B ACTIVITY
IN THE YOUNG ADULT POPULATION

The cytotoxic T cell response in vaccinated young adults was measured as levels
o f granzyme

B

activity

using

N-t-butyloxycarbonyl-Lalanyl-L-alanyl-L-aspartyl-

paranitroanilide (BAAD-pNA) substrate. Serial measures o f the levels o f granzyme B
activity in virus-stimulated peripheral blood mononuclear cells in vaccinated young
adults were completed to determine the changes in granzyme B levels over time in
culture following influenza vaccination. In vitro cytotoxic T cell responses were then
compared to the ex vivo responses. In order to optimize the conditions for measuring ex
vivo cytotoxic T cell levels o f granzyme B activity, we used different concentrations o f
interleukin-7 in virus-activated peripheral blood mononuclear cell cultures and measured
granzyme B activity at different time points in the cultures.

Preliminary studies
The initial study measured the kinetics o f granzyme B production in peripheral
blood mononuclear cell cultures in two types o f culture medium.

We obtained blood

samples from healthy young adult subjects at several time points following vaccination
with the 1998-1999 trivalent influenza vaccine.

Peripheral blood mononuclear cells

isolated from these blood samples at twelve weeks post vaccination were stimulated with
live influenza A/Nanchang/933/95 (H 3 N 2 ) (1 0 5 TCID so/m L) and harvested on each day
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five to nine in either Aim V culture medium or RPMI 1640 culture medium
supplemented with 5% fetal bovine serum.

The peak granzyme B activity, using the

BAAD-pNA substrate in the granzyme B assay, occurred on day
culture medium (Figure 3).

6

in Aim V tissue

This data corresponded to earlier studies using N-t-

butyloxycarbonyl-L-alanyl-L-alanyl-L-aspartyl-thiobenzyl ester (BAADT) substrate in
the granzyme B assay.

The peak o f granzym e B activity in peripheral blood

mononuclear cells stimulated in RPMI medium supplemented with 5% FBS was poorly
defined, potentially due to the effects of the fetal bovine serum in these cultures. Thus,
Aim V medium was confirmed to be the medium o f choice for all o f the peripheral blood
mononuclear cell cultures.
To test for variability within the assay, blood samples were obtained from healthy
young adults, who had been vaccinated with the 1998-1999 trivalent influenza vaccine
twelve weeks previously, and stimulated in vitro with live influenza A/Nanchang/933/95
(H?N2) virus in Aim V medium. Several cell lysates (a minimum o f three) were prepared
for each young adult subject from this blood collection.

The interassay variability in

healthy young adults was < 1 0 % and within acceptable limits for a biological assay
(Figure 4A).
The reproducibility o f the granzyme B assay was examined using healthy young
adults who had been vaccinated with the 1998-1999 trivalent influenza vaccine thirty-six
weeks previously, and stimulated in vitro with live influenza A/Sydney/5/97 (H 3 N 2 )
virus. Blood samples were obtained on three different days within a seven-day period
and granzyme B activity levels were measured in three separate experiments. Significant
reproducibility o f the granzyme B activity levels w as apparent in the in vitro experim ents
(Figure 4B).
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Fig. 3: Determination of peak in vitro granzyme B activity (twelve weeks post
vaccination) in various culture media. Mean values from three different subject lysates
are shown here. Error bars represent the standard deviation o f the assay within subjects.
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Error bars represent standard deviation within the assay, which may be too small to be
visualized.
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Fig. 4B: Reproducibility o f the granzyme B activity assay (using three blood samples
thirty-six weeks post vaccination). Mean values from triplicate samples o f each blood
draw are shown.
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In vitro CTL response to influenza vaccination

Granzyme B activity levels were measured in influenza A/Nanchang/933/95
(H 3 N 2 ) stimulated peripheral blood mononuclear cell cultures o f healthy vaccinated
young adults over a period o f thirty-six weeks to determining the sensitivity o f the
granzyme B activity assay using BAAD-pNA substrate. Peripheral blood m ononuclear
cells were isolated from the healthy young adult subjects at three different time points —
four, twelve and thirty-six weeks post vaccination with the 1998-1999 trivalent influenza
vaccine.

The granzyme B activity o f peripheral blood mononuclear cells o f healthy

vaccinated young adults at twelve weeks post vaccination (Figure 5) is com parable to
earlier studies (M cElhaney et al„ 1996).

This study suggests that cytotoxic T cell

memory following vaccination declines after four weeks, suggesting a relatively short
duration o f cytotoxic T cell memory in young adults. Cytotoxic T cell responses to live
influenza virus as measured by in vitro restimulation (using 5IC r release or granzym e B
assays) are relatively short in duration and may result from a primary as well as a
secondary response to influenza vaccination.

E x vivo CTL response to influenza vaccination
To obtain an assessment o f the in vivo response to influenza vaccination, we
developed an ex vivo assay o f virus-activated peripheral blood mononuclear cell cultures,
which had been stimulated in culture for different periods o f time (six to thirty-one
hours) to study the kinetics o f granzyme B activity in ex vivo cultures.

The optimal

conditions for measuring granzyme B response to influenza was determined in the ex
vivo cultures supplemented with interleukin-7.
Figure

6

depicts the study o f the dose-response o f interleukin-7 over a
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triplicate samples are shown. Error bars represent standard deviation within the assay.
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: Effect o f interleukin 7 on ex vivo CTL response (twelve weeks post vaccination)

to live influenza A/Nanchang/933/95 (H 3 N2) virus stimulation.

Mean values from

triplicate subjects are shown. Error bars represent the standard error o f the mean, which
may be too small to be visualized.
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from 12.5 to 37.5 ng/mL on granzyme B levels in the cultures from healthy young adults
who had been vaccinated with the 1998-1999 trivalent influenza vaccine.

Peripheral

blood m ononuclear cells were obtained from blood samples collected from the young
adult

subjects twelve weeks post-vaccination.

The

optimum

concentration

of

interleukin-7 for maximum granzyme B activity was 25 ng/mL. The addition o f 12.5
ng/mL o f interleukin-7 to the peripheral blood mononuclear cell cultures resulted in
activation o f the C D 8 ~ T cells occurring at approximately the same rate as the peripheral
blood m ononuclear cell culture that had not been stimulated with interleukin-7.

The

supplementation o f 37.5 ng/mL interleukin-7 to the cultures caused only a sight increase
in activation o f the CD 8 ' T cells. The effect o f interleukin-7 on the virus-stimulated
peripheral blood mononuclear cells after 17 hours appears to be a direct effect on the
CD 8 ’ T cells, w hich results in activation o f the cells over a short time period without
stimulating a proliferative response, thereby increasing the precursor frequency o f virusspecific cytotoxic T cells.

These data demonstrates that the frequency o f precursor

memory cytotoxic T cell can be accurately measured in ex vivo peripheral blood cell
cultures to determ ine the cytotoxic T cell response to influenza vaccination.
The reproducibility o f the ex vivo granzyme B assay was determined at thirty-six
weeks post vaccination in healthy young adults. Figure 7 depicts the reproducibility o f
the assay from measurem ents of granzyme B activity in three separate blood draws over
a seven-day period and identical culture conditions

The data had similar levels o f

granzyme B activity as determined in the in vitro experiments (Figure 4B).
We now needed to determine the frequency o f the ex vivo response to influenza
vaccination.

Using the granzyme B assay, the response to influenza vaccination in

young adults has been determined by measuring a concentration o f cells in culture.
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Determining the ex vivo response to influenza vaccination on a per cell basis will help
clarify the relationship between granzyme B and cytotoxic T cell response to influenza
vaccination.
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CHAPTER IV

RESULTS: MEASUREMENT OF VIRUS-SPECIFIC CTL
FREQUENCY IN THE YOUNG ADULT POPULATION

Microbe-derived peptides from the influenza virus are generated by intracellular
processing o f replicating influenza virus, bound to major histocompatibilty com plex
class I molecules, and transported to the cell surface o f infected cells.

Virus-specific

cytotoxic T cells recognize the major histocompatibilty complex and upon activation,
secrete interferon y. Using a monoclonal anti-interferon y antibody and biotinylated
monoclonal anti-interferon y antibody pair, the number o f activated virus-specific T cells
was determined. This technique is the basis o f the enzyme-linked immunospot (ELIspot)
assay and is able to directly measure the frequency o f epitope-specific T cells (Lalvani et
al.. 1997; Czerkinsky et al., 1988).

The measurement of proliferation o f T cells in

response to their specific antigen has previously been performed using the limiting
dilution technique and chromium-release assay in order to determ ine the num ber o f
antigen specific T cells.

The ELIspot assay has the advantage o f detecting cytokine

release in response to antigen stimulation on a single cell level, thereby permitting direct
calculation o f T cell frequencies by volume o f blood.

Preliminary study
Initially, influenza virus-specific precursor frequency was measured as the
number o f interferon y producing cells in the cell cultures in healthy young adults, using

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

47
the ELIspot technique.

Peripheral blood mononuclear cells were obtained from the

healthy young adult subjects twelve-weeks post-vaccination with the 1998-1999 trivalent
influenza vaccine and stim ulated with live influenza A/Nanchang/933/95 (H 3 N 2 ) virus.
One o f the young adult subjects donated their blood twice during a one-w eek period of
time

Reproducibility o f the ELIspot technique was determined in one healthy adult

subject, showing no significant variation in the number o f interferon y (“ ELIspots'7) spots
(Figure

8

).

The frequency o f virus-specific precursor T cells within the total cell

population o f the healthy young adult subjects was determined to be 170.63 ± 15.45 (SE)
interferon

7

producing cells within 5 x 106 cells in culture.

Effect of interleukin 7 on ELIspot technique
In order to determine if the supplementation o f 25 ng/mL o f interleukin-7
affected the live influenza A/Nanchang/933/95 (H3 N2 ) virus stim ulation o f ex vivo
lymphocytes, a study was performed using the ELIspot assay in the presence and absence
o f interleukin-7. Peripheral blood mononuclear cells were obtained from healthy young
adults who had been vaccinated with the 1998-1999 trivalent influenza vaccine twelve
weeks

previously.

The

cell

cultures

were

stimulated

with

live

influenza

A/Nanchang/933/95 (H3 N 2 ) virus for 17 hours either in the presence or absence of
interleukin-7

supplementation

(25

ng/mL).

The

effects

of

live

influenza

A/Nanchang/933/95 (H3 N 2 ) virus stimulated ex vivo lymphocytes supplem ented with and
without 25 ng/mL interleukin 7 are shown in Figure 9. These results can be interpreted
to mean that the precursor frequency o f virus-specific cytotoxic T cells do not
appreciably change with the addition o f interleukin-7, consistent with the observations
that a primary response is not stimulated under these conditions.
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. Kx vivo virus-specific CTL response to stimulation with live influenza

A/Nanchang/933/95 (H 3 N 2 ) virus 12 weeks post vaccination.

Mean ELIspot values

from quadruplicate wells are shown. Error bars represent standard deviation within the
assay, which may be too small to be visualized.
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Fig. 9: Effect o f interleukin 7 on virus-specific CTL response to live influenza
A/Nanchang/933/95 (H 3 N 2 ) virus stimulation 12 weeks post vaccination. The negative
control was not stimulated. The positive control was stimulated with concanavalin A.
Mean ELIspot values from three subjects are shown. Error bars represent standard error
o f the mean, which may be too small to be visualized.
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CD8^ T cell response to influenza vaccination
We initially investigated the frequency o f influenza virus-specific cells within the
influenza stimulated ex vivo lymphocytes in the absence o f CD 8 * T cells.

Peripheral

blood mononuclear cells were obtained from healthy young adults, who had been
vaccinated with the 1998-1999 trivalent influenza vaccine twelve weeks previously.

CD 8 ' T cells were removed from peripheral blood mononuclear cell preparations and
were com pared to non-depleted peripheral blood mononuclear cells in cultures
stim ulated w ith live influenza A/Nanchang/933/95 (H3N2) virus under ex vivo conditions
in the ELIspot assay. The frequency influenza virus-specific cells within depleted C D 8 ~

T cell population was decreased by 17% in comparison to the total cell population
(Figure 10), suggesting the CD 8 ~ T cell population represent a significant proportion but
not all o f the interferon y producing cells in the culture.
The frequency o f influenza virus-specific cells within the influenza activated ex
vivo lymphocytes may have resulted from several cell types - CD 8 ’ T cells, natural killer
cells and C D 4' T cells. To determine the precursor cytotoxic T cell frequency in young
adults, peripheral blood mononuclear cells were obtained from healthy young adults
thirteen weeks post vaccination. Using negative selection techniques, the natural killer
cells and CD4

T cells were removed from the peripheral blood mononuclear cell

cultures. Figure 11 can be interpreted to mean that the peripheral blood mononuclear cell
population, which had been negatively selected for C D 8 * T cells (i.e. CD4’ CD 59'
peripheral blood m ononuclear cells), contained a higher frequency o f influenza virusspecific cells than the total cell population (non-selected peripheral blood mononuclear
cells).
The ratio o f interferon-y producing C D 4‘ T cells and natural killer cells to C D 8 *
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Fig. 10: Virus-specific CTL response to live influenza A/Nanchang/933/95 (H 3 N 2 ) virus
stimulation 12 weeks post vaccination in the absence o f C D 8 ' T cells. The negative
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Mean ELIspot values from three subjects are shown. Error bars represent standard error
o f the mean, which may be too small to be visualized.
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Identification o f virus-specific CD 8

CTL response to live influenza

A/Nanchang/933/95 (H3 N2 ) virus stimulation 13 weeks post vaccination. Mean ELIspot
values from three subjects are shown. Error bars represent standard error o f the mean,
which may be too small to be visualized.
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T cells in the peripheral blood mononuclear cell cultures was 1:46 virus-specific
precursor T cells.

These data imply that the interferon y producing cells are largely

derived from cytotoxic T cell population and is consistent with previously published
work (Taylor et al., 1985).
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CHAPTER V

RESULTS: IDENTIFICATION OF THE EFFECT OF AGING ON THE CTL
RESPONSE TO INFLUENZA VACCINATION AND
CROSS-REACTIVITY BETWEEN VARIOUS INFLUENZA STRAINS

We have demonstrated that a live influenza virus stimulates granzyme B activity
under the ex vivo and in vitro culture conditions in healthy young adult population and
can be used to track the response to vaccination. To determine the effect o f age on crossreactivity o f the granzyme B response between different influenza A/H3 N2 strains, we
compared healthy young adults to healthy older adults.

The ex vivo and in vitro

cytotoxic T cell response to influenza vaccination in young adults has been shown to be
comparable in terms o f granzyme B activity (Figure 5 and Figure

6

).

The correlation

between the ex vivo and in vitro granzyme B activity levels and frequency o f influenza
virus-specific cytotoxic T cell suggested that the in vitro restimulation o f the response to
influenza vaccination was similar to the ex vivo measurements. To determine the effects
o f aging on the granzym e B response to influenza vaccination, we compared healthy
young adults to healthy older adults cytotoxic T cell response to influenza vaccination.

CTL response measured via granzyme B assay
In order to determine the effect o f age on influenza A/H3 N 2 strain-related changes
in granzyme B production, a study containing ten healthy young adults and ten healthy
older adults was completed. Blood samples from these 20 subjects were obtained prior
to and four weeks following vaccination with the 1999-2000 trivalent influenza vaccine.
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Peripheral blood mononuclear cells were isolated from these blood samples and
stimulated with live virus preparations o f influenza A/Sydney/5/97 (H 3 N 2 ), influenza
A/Nanchang/933/95 (H 3 N 2 ), or influenza A/Johannesburg/33/94 (H 3 N 2 ).

This study

measured the ex vivo and in vitro granzyme B activity in the healthy young and healthy
older adult subjects as well as determining the frequency o f influenza virus-specific
cytotoxic memory T cells in both populations.
Granzyme B activity measured ex vivo in the healthy young and healthy older
adult populations groups were increased four weeks post vaccination, as illustrated in
Figure 12

The amount o f stimulation within the cell cultures differed from one

influenza H3 N 2 strain to another. The largest granzyme B response was demonstrated to
the vaccinating strain, influenza A/Sydney. The increase in ex vivo granzyme B activity
from pre- to post-vaccination o f the healthy young adult subjects was statistically
significant in both age groups (p < 0.05, paired student’s t test) for the three different
H 3 N 2 strains o f live influenza A virus. The levels o f ex vivo granzyme B activity in the
healthy young adults compared to the healthy older adults was significantly higher (p <

0.05. Mann-Whitney U test) for the three different influenza A/H3 N2 strains, consistent
with an age-related decline in the cytotoxic T cell response to vaccination.
Granzyme B activity measured in vitro in the healthy young and older adults
were increased four weeks post vaccination, as illustrated in Figure 13.

The in vitro

granzyme B activity were determined to be almost identical to the ex vivo granzyme B
activity in both the healthy young and older adult populations.

We had expected the

levels o f granzyme B activity in vitro to have increased in comparison to the ex vivo
granzyme B activity because the number of cells in the in vitro cultures should have
increased and therefore produced more granzyme B within these cells. The in vitro cell
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cultures produced slightly higher protein levels in comparison to the protein level o f the
ex vivo cell cultures. The frequency o f influenza-specific cytotoxic T cells in the in vitro
cultures increases with time in culture in comparison to the ex vivo cultures.

This

increase in protein levels may have occurred due to cell proliferation of the in vitro cell
cultures over the

6

-day culture period.

This may consequently have affected the

calculation o f granzyme B activity in the in vitro cultures, yielding apparently similar
levels o f in vitro and ex vivo granzyme B activity.
The in vitro granzyme B activity in both age groups corresponded to previously
reported granzyme B activity (McEIhaney et al., 1996). W e also observed the granzyme
B activity to be greater in the healthy young adult population in comparison to the
healthy older adult population similar to McEIhaney et al. (1996). The shorter time
period (17 hours in culture) for the ex vivo procedure provides confidence that the
granzyme B activity being measured is not a result o f cell proliferation and
differentiation in culture over time.

Virus-specific CTL response to influenza vaccination
The number o f cytotoxic T cells producing interferon y was determined via
ELIspot detection o f influenza virus-specific CD 8 ' T cells in the healthy young and
healthy older adult populations.

Influenza vaccination enabled the healthy older adult

population to increase their number o f influenza virus-specific cytotoxic T cells to a level
approximately equal to the healthy young adult population prior to influenza vaccination
(Figure 14).

The increase in the number o f influenza virus-specific memory cytotoxic T

cells from pre- to post-vaccination o f the healthy young adult population was statistically
significant (p < 0.05, paired student’s t test) for each o f the three influenza A/H 3 N 2
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Fig. 14: Virus-specific CD8* CTL response (17 hours in culture) to live influenza
A/H3N2 virus stimulation. Cultures were negatively selected for C D 8' T cells.

(10

subjects per population group, 0 = prior to vaccination, 4 = 4 weeks post vaccination).
Sample mean values are shown. Error bars represent 95% confidence intervals.
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strains. The number o f influenza A/Nanchang (H jN 2) and A/Johannesburg (H 3 N 2 ) virusspecific memory cytotoxic T cells were significantly higher (p < 0.05, Mann-W hitney U
test) in the young adult population compared to the older adult population across the
three different H 3 N 2 strains.

A similar comparison o f influenza A/Sydney (H 3 N 2 )

stimulated memory T cells illustrated no statistical significance, which may have resulted
from the small sample size o f the young and older adult populations or recent prior
exposure to the circulating strain.
The comparison

o f influenza A/Sydney (H 3 N 2 ) virus-stimulated

memory

cytotoxic T cells prior to vaccination to post vaccination in the older adult population
resulted in statistical significance (p = 0.015, paired student’s t test).

The influenza

A/Sydney (H 3 N 2 ) virus-stimulated memory cytotoxic T cells o f the healthy young adult
population compared pre- to post-vaccination frequencies were not statistically different;
this may reflect a Type II error due to the small sample size.

Influenza vaccination

increases the number o f virus-specific cytotoxic T cells by approximately 50% in the
healthy older adult population (Figure 14).

Effects of aging on immune response
The ratio o f the granzyme B level to the number o f influenza virus-specific CD8~
T cells was calculated to determine the amount o f granzyme B activity measured on a per
cell basis. In the young adult population, there was a four-fold increase in the amount o f
granzyme B activity produced on a per cell basis, while the level increased only two fold
in the older adult population (Table 1). This fold-increase in the granzyme B level per
cell was consistent across the three H3N2 strains o f influenza virus within each age group.
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Table 1
Ratio o f Granzyme B Activity per Influenza virus-specific CD8~ T Cell
Stimuli in Culture

1
1I

Young Adults

Influenza

Influenza

Influenza A/Sydney

A/Nanchang

A/Johannesburg

0.0020

0.0018

0.0016

0.0018

0.0015

0.0012

0.0079

0.0056

0.0040

0.0036

0.0031

0.0023

Prior to
Vaccination

Older Adults
Prior to
Vaccination

Young Adults 4
Weeks Post
Vaccination

Older Adults 4
Weeks Post
Vaccination
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This difference was statistically significant (p = 0.04, Mann-Whitney U test) for
influenza A/Sydney (H 3 N 2 ) stimulated peripheral blood mononuclear cells.
We have determined that the granzyme B levels increase after stimulation with
influenza virus as result o f the activation of memory cytotoxic T cells.

Although the

frequency o f virus-specific cytotoxic T cells does not linearly correlate with the
granzyme B levels, it suggests that the increase in number o f virus-specific cytotoxic T
cells in response to a killed influenza virus vaccine may occur via a different mechanism
than that which increases granzyme B levels. The effect o f aging on the cytotoxic T cell
response to influenza vaccination is that the granzyme B levels are less effectively
stimulated in healthy older adults compared to healthy young adults when using an
inactivated influenza vaccine.
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CHAPTER VI

CONCLUSIONS

T cell responses to influenza vaccination are affected by numerous variables. The
strain o f influenza virus within the vaccine as well as age, specific chronic illness, and
frailty may contribute to the variations in the T cell response to influenza vaccination.
Although the cytotoxic T cell response to influenza vaccination has been studied, a
limited number o f studies have compared the responses between different age groups
(Gorse and Belshe, 1990; Powers, 1993; Powers and Belshe, 1993).
We initially investigated the in vitro cytotoxic T cell response to influenza
vaccination in healthy young and older adults using the granzyme B assay (ex vivo and in
vitro) and frequency of virus-specific cytotoxic T cells as a measure o f the cytotoxic T
cell response between these two different age groups. Our results are consistent with
previously published results (McElhaney et al., 1996; McElhaney et al.. 1998) using a
modified version o f the granzym e B assay for this study.

Our laboratory observed a

decreased in vitro cytotoxic T cell response to influenza vaccination in the healthy older
adult population in comparison to the healthy young adult via the granzyme B assay.
The ex vivo granzym e B activity were similar to the in vitro granzyme B activity.

In

these in vitro stimulated cultures, the observed granzyme B activity levels m ay have
resulted in the stimulation o f the primary as well as the secondary response to stim ulation
with live influenza virus. Thus, we developed an ex vivo granzyme B assay to elim inate
the effects o f proliferation and differentiation o f the cells occurring in 6 days o f culture.
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The in vitro cell cultures produced on average slightly higher protein levels in
comparison to the ex vivo cell cultures. The increased protein levels may have resulted
due to the differentiation o f the cultures over time. The increased protein levels may have
affected the determination o f granzyme B activity in the in vitro samples.

The similar

levels o f granzyme B activity determined ex vivo and in vitro may have resulted from the
manner in which granzym e B activity is calculated; when the protein levels are increased
the granzym e B levels will decrease. The increased protein levels may have caused the
ex vivo and in vitro granzym e B levels to appear to be similar, although there is an
increase in the frequency o f cytotoxic T cells in the in vitro cultures, which should have
resulted in higher granzym e B levels in vitro.
To directly measure the age-related changes in the response to influenza
vaccination, ex vivo cell cultures of healthy young and older adults were stimulated with
live influenza virus and the cytotoxic T cell response to influenza vaccination was
measured using the granzyme B assay.

The ex vivo cytotoxic T cell response to

influenza vaccination in healthy young and healthy older adult populations produced
levels o f granzyme B activity, that were comparable to the in vitro granzyme B activity
observed in our laboratory. This data validates our previous results m easuring granzyme
B activity within in vitro cultures. However, there may be differences in the mechanism
by which granzyme B activity levels are increased and does not necessarily reflect the
total am ount o f granzym e B activity in ex vivo cultures compared to the in vitro cultures.
The ex vivo granzym e B assay differs from the in vitro granzyme B activity assay
in the tim e period required for cell culture, as well as the supplementation o f interleukin7 to the cultures.

The presence o f interleukin-7 increases the level o f granzyme B

measured at 17 hours by shortening the period o f time over which virus-specific
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cytotoxic T cells are activated and thus provides a more accurate assessment of the in
vivo environment.
The effect o f age-related changes on the cytotoxic T cell response to influenza
vaccination was investigated in ex vivo and in vitro influenza virus-stimulated cultures o f
the healthy young and older adult populations. The cultures were stimulated with three
different H 3 N 2 strains o f live influenza subtype A virus. The largest ex vivo and in vitro
granzyme B activity was observed for the most recent circulating H3N2 strain o f
influenza A virus (A/Sydney) in both the healthy young and older adult population. The
magnitude o f the cytotoxic T cell response to influenza vaccination was decreased in the
healthy older adult population when compared to the healthy young adult population,
consistent with an age-related decline in the cytotoxic T cell response to vaccination.
In order to determine if the decreased granzyme B response in the healthy older
adults compared to the healthy young adults resulted from a change in the frequency o f
the cytotoxic T cells, the number o f the interferon y producing cells in CD 8 ~ T cell
cultures was compared between the two age groups. The frequency o f influenza virusspecific CD 8 * T cells o f the healthy young and healthy older adults demonstrated similar
trends to the various influenza A/H3N2 stimulation as the ex vivo and in vitro granzyme B
activity levels (i.e. response to A/Sydney being the greatest).

The frequency o f the

cytotoxic T cell response in the older adult population increased after influenza
vaccination showing that stimulation o f the influenza virus- specific cytotoxic T cells is
similar to the young adult population. This observation indicates that the aging process
may affect the granzyme B levels within the cytotoxic T cells o f older adults. Thus, the
function o f activating granzyme B within the influenza-infected cells o f older adults may
be defective in some manner.
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The health status in older adults has been shown to impact on the protective
ability o f influenza vaccination.

A decline in cell-mediated immunity in older adults

may result due to health status, causing a deficient T cell response to influenza
vaccination.

T helper cell responses have been determined to be subtype specific to

various influenza virus strains, while the cytotoxic T cell response is type-specific
between various strains o f influenza A (e.g. H iN t and H3N2) virus (M bawuike et al.,
1993; Powers and Belshe, 1993; Gorse and Belshe, 1990). These studies conducted in
older adult subject populations have shown variations in the cross-reactivity o f T cell
responses to different strains o f killed influenza virus.

A broader cytotoxic T cell

response after infection with live influenza virus has been previously reported in the
murine model (Webster and Askonas, 1980; Askonas and Taylor,

1983).

The

stimulation o f the T cell response with live influenza virus in ex vivo cultures appears to
indicate that the variations in cross-reactivity to different strains o f influenza virus are
able to be decreased using live influenza vaccines.
Three different H 3 N 2 strains o f live influenza subtype A virus were used to
stimulate the cross-reactive response o f the cytotoxic T cell in both ex vivo and in vitro
peripheral blood mononuclear cell cultures o f healthy young and older adults.
Stimulation o f the cytotoxic T cell response by the nuclear proteins o f the live influenza
virus has been previously determined to be cross-reactive for all strains within the
subtypes of influenza virus. The cross-reactive immune responses to influenza virus o f a
different subtype than initially encountered is thought to be mediated by the cytotoxic T
cells specific for the influenza nucleoprotein (a conserved gene) (Townsend et al., 1984;
Yewdell et al.. 1985; Taylor et al., 1987; Wraith et al., 1987). The memory cytotoxic T
cells would then recognize all strains within a type o f influenza virus. Amino acid
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changes accumulate in all eight o f the influenza RNA segments after formation o f the
viral RNA segments during viral replication. Influenza A/H 3 N 2 virus is able to change
on a yearly basis due to subtle nucleotide changes coding for the amino acids within the
viral surface proteins.
The cytotoxic T cell response after stimulation with three different influenza A/
H 3 N 2 strains illustrated the largest increase o f memory cytotoxic T cell response to
influenza A/Sydney in both the healthy young and older adult populations. The resting
memory cytotoxic T cells appear to reside in the immune system for years after exposure
to the influenza virus in both healthy young and older adults, as shown by the number o f
virus-specific cytotoxic T cells in influenza A/Johannesburg/33/94 activated cultures.
The results for this research project serve as the basis for the investigation o f the
mechanism o f decline in cellular-mediated immunity in the healthy older adult
population. This project has provided a basis for future characterization o f the cytotoxic
T cell response to influenza vaccination in the aging population. The ability to measure
the cytotoxic T cell response in ex vivo cell cultures will result the understanding o f the
in vivo response to influenza vaccination in human subjects.
The information gained from this project has now provided evidence that the
cytotoxic T cell response in the older adult population may be affected by a mechanistic
defect in one o f the cytolytic mediated pathways o f killing influenza-infected cells.
Future studies addressing these mechanistic questions concerning cytotoxic T cells in
healthy young and older adults will need to be completed using larger subject
populations to determine if the health or gender have an effect on the cytotoxic T cell
response to influenza vaccination.

An investigation o f the activation o f perforin-

mediated killing pathway on a biochemical level will enable the determination o f a
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possible defect in the perforin or granzyme B at the level o f messenger RNA production,
which would result in an increased production o f fas ligand messenger RNA, a
compensatory mechanism. The cleavage mechanism o f granzym e B from the precursor
enzyme to the active form o f the enzyme within the cytotoxic T cell may also impair the
perforin-mediated killing pathway.

An examination o f perforin, granzyme B and fas

ligand at the levels o f transcription and translation will lead to a more complete
understanding o f the components of the cytolytic mediated pathways o f killing influenzainfected cells.

The identification o f these specific-components o f cytolytic killing

pathways will result in the determination o f the age-related defects that decrease the
cytotoxic T cell response to influenza vaccination.
The results from this project can be an explanation o f the declining
cellular-mediated immune response in healthy older adults.
techniques developed to measure cellular-mediated
investigation

o f the

subject-

and

health-related

The relatively simple

immunity will allow further
variables

associated

with

immunological response to influenza vaccination o f the elderly population.

the
The

characterization o f the ex vivo cytotoxic T cell response to vaccination will provide a
greater understanding o f the in vivo response to vaccination and may aide in a better
comprehension o f the protective mechanisms o f vaccination in the elderly population.
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